Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma
Clinical trial NCT02023710 · UNKNOWN
Trial details
- NCT number
- NCT02023710
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2017-12-01
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.